Our colleagues at Entrée Health recently published a case study showcasing how a leading oncology company was able to streamline hub communications, spurring engagement and helping patients and HCPs get support easier and faster than ever.
If this case study leaves you hungry to learn more, register to watch our webinar, Reimbursement Blueprint: A 4-Step Guide to a Successful Pharmaceutical HUB. It’s available free and on demand.
Archbow Consulting, Entrée Health, and Valuate Health Consultancy are sister companies under the Value and Access division of Omnicom Health Group. Learn more about our united organizations here.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
Navigating Pharmacy Types for Commercialization Success
The pharmaceutical market is evolving fast, and delivering prescriptions efficiently is more challenging than ever. The right pharmacy dispensing strategy can be the difference maker between commercial success and missed opportunities.
DTC/DTP + Telemedicine – The Next Big Thing in Pharma?
The May 2025 Executive Order marks a seismic shift in the U.S. pharmaceutical patient access market.
Evolving Pharma: How DTC/DTP and Telemedicine are Redefining the Industry’s Future
By understanding DTC, DTP and the intersection with telemedicine, pharma can deliver more value to patients and drive measurable results.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|


